跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EMTRICITABINA/TENOFOVIR DISOPROXILO TILLOMED 200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EMTRICITABINA/TENOFOVIR DISOPROXILO TILLOMED 200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
EMTRICITABINA/TENOFOVIR DISOPROXILO TILLOMED 200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Laboratorios Tillomed Spain S.L.U
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 25, 2020
Approval ID
ae6ea094877e1b4e
Company
Laboratorios Tillomed Spain S.L.U
Type
Standard
Approval Details
Approval Id
ae6ea094877e1b4e
Drug Cima Aemps Name
EMTRICITABINA/TENOFOVIR DISOPROXILO TILLOMED 200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85198
Holder Company Name
Laboratorios Tillomed Spain S.L.U
Marketing Company Name
Laboratorios Tillomed Spain S.L.U
Authorization Date
2020-06-25
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
200 mg /245 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Laboratorios Tillomed Spain S.L.U
Active Ingredients
EMTRICITABINA
200 mg
TENOFOVIR DISOPROXILO FUMARATO
300 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 25, 2020
Approval ID
ae6ea094877e1b4e
Type
Standard
Back to CIMA-AEMPS Approvals